摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methylisatin-3-oxime | 13208-98-5

中文名称
——
中文别名
——
英文名称
5-methylisatin-3-oxime
英文别名
5-methylisatinmonoxime;5-methyl-indoline-2,3-dione-3-oxime;5-Methyl-indolin-2,3-dion-3-oxim;3-(hydroxyamino)-5-methylindol-2-one
5-methylisatin-3-oxime化学式
CAS
13208-98-5
化学式
C9H8N2O2
mdl
MFCD00456532
分子量
176.175
InChiKey
CLCPDOODLNLAPB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    224-225 °C
  • 密度:
    1.42±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.47
  • 重原子数:
    13.0
  • 可旋转键数:
    0.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    61.69
  • 氢给体数:
    2.0
  • 氢受体数:
    3.0

安全信息

  • 海关编码:
    2933790090
  • 包装等级:
    II
  • 危险类别:
    4.1
  • 危险性防范说明:
    P201,P202,P280,P210,P240,P264,P270,P301+P310,P330,P370+P378,P403+P233,P405,P501
  • 危险品运输编号:
    1325
  • 危险性描述:
    H228,H302,H317,H319,H341,H351,H411

SDS

SDS:75d6f8feb8708e51958e6554d23e4e48
查看

反应信息

点击查看最新优质反应信息

文献信息

  • A novel strategy to the synthesis of 4-anilinoquinazoline derivatives
    作者:Zheng Wang、Cuiling Wang、Yanni Sun、Ning Zhang、Zhulan Liu、Jianli Liu
    DOI:10.1016/j.tet.2013.12.028
    日期:2014.1
    A novel approach to prepare 4-anilinoquinazoline derivatives based on the transformation of indoline-2,3-dione to formamidine was developed. The processes with this approach are simple, efficient, and environmentally friendly. The efficiency of this approach was evaluated by synthesizing 17 4-anilinoquinazolines and comparing the obtained yields with those achievable through conventional synthetic
    开发了一种基于吲哚啉-2,3-二酮向甲am的转化制备4-苯胺基喹唑啉衍生物的新方法。使用这种方法的过程简单,高效且对环境友好。通过合成17种4-苯胺基喹唑啉并将获得的收率与通过常规合成方法可获得的收率进行比较,评估了该方法的效率。这是第一次合成化合物8d,8e,8h和13b - f。观察到这些化合物的IR和UV光谱的特征以及它们的取代基对光谱的影响。
  • [EN] N-{[2-(PIPERIDIN-1-YL)PHENYL](PHENYL)METHYL}-2-(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXA ZIN-7-YL)ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ROR-GAMMA MODULATORS FOR TREATING AUTOIMMUNE DISEASES<br/>[FR] DÉRIVÉS DE N-{[2-(PIPÉRIDIN-1-YL)PHÉNYL](PHÉNYL)MÉTHYL}-2-(3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXA ZIN-7-YL)ACÉTAMIDE ET COMPOSÉS APPARENTÉS UTILISÉS EN TANT QUE MODULATEURS DE ROR-GAMMA POUR LE TRAITEMENT DE MALADIES AUTO-IMMUNES
    申请人:GENFIT
    公开号:WO2018138362A1
    公开(公告)日:2018-08-02
    The present invention provides e.g. N-[2-(piperidin-1-yl)phenyl] (phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating e.g. autoimmune diseases, autoimmune-related diseases, inflammatory diseases, metabolic diseases, fibrotic diseases or cholestatic diseases, such as e.g. arthitis and asthma.
    本发明提供了例如N-[2-(哌啶-1-基)苯基](苯基)甲基}-2-(3-氧代-3,4-二氢-2H-1,4-苯并噁嗪-7-基)乙酰胺衍生物和相关化合物,作为ROR-gamma调节剂,用于治疗例如自身免疫疾病、自身免疫相关疾病、炎症性疾病、代谢性疾病、纤维化疾病或胆汁淤积性疾病,例如关节炎和哮喘。
  • Use of isatin derivatives as ion channel activating agents
    申请人:——
    公开号:US20020016354A1
    公开(公告)日:2002-02-07
    The present invention relates to ion channel activating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as openers of SK Ca and IK Ca channels. In further aspects, the present invention relates to the use of these SK/IK channel activating agents for the manufacture of medicaments and pharmaceutical compositions comprising the SK/IK channel activating agents. The SK/IK channel activating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK channels, in particular respiratory diseases such as asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, urinary incontinence, bladder outflow obstruction, irritable bowel syndrome, gastrointestinal dysfunction, secretory diarrhea, ischaemia, cerebral ischaemia, ischaemic heart disease, angina pectoris, coronary heart disease, traumatic brain injury, psychosis, anxiety, depression, dementia, memory and attention deficits, Alzheimer's disease, dysmenorrhea, narcolepsy, Reynaud's disease, intermittent claudication, Sjorgren's syndrome, migraine, arrhythmia, hypertension, absence seizures, myotonic muscle dystrophia, xerostomi, diabetes type II, hyperinsulinemia, premature labor, baldness, cancer, and immune suppression.
    本发明涉及离子通道激活剂。更具体地说,本发明涉及一类特定的化合物,已被证明对SKCa和IKCa通道的开放具有用处。在进一步方面,本发明涉及利用这些SK/IK通道激活剂制造药物和包含SK/IK通道激活剂的药物组合物。本发明的SK/IK通道激活剂对于治疗或缓解与SK/IK通道相关的疾病和症状非常有用,特别是呼吸道疾病,如哮喘、囊性纤维化、慢性阻塞性肺疾病和鼻涕,痉挛、血管痉挛、冠状动脉痉挛、肾脏疾病、多囊肾病、膀胱痉挛、尿失禁、膀胱排空阻塞、肠易激综合征、胃肠功能障碍、分泌性腹泻、缺血、脑缺血、缺血性心脏病、心绞痛、冠心病、创伤性脑损伤、精神病、焦虑、抑郁、痴呆、记忆和注意力缺陷、阿尔茨海默病、痛经、嗜睡症、雷诺氏病、间歇性跛行、斯约格伦综合征、偏头痛、心律失常、高血压、缺席性癫痫发作、肌肉肌无力、干燥综合征、2型糖尿病、胰岛素过多症、早产、秃头、癌症和免疫抑制。
  • Copper-Catalyzed Carbonyl Group Controlled Coupling of Isatin Oximes with Arylboronic Acids To Prepare <i>N</i> -Aryloxindole Nitrones
    作者:Xue-Ling Mo、Chun-Hua Chen、Cui Liang、Dong-Liang Mo
    DOI:10.1002/ejoc.201701324
    日期:2018.1.17
    prepared in good to excellent yields by copper-catalyzed coupling of N-unprotected isatin oximes with aryl boronic acids under mild reaction conditions. The reaction was tolerant various arylboronic acids with diverse sensitive functional groups. Detailed studies showed that the carbonyl group in isatin oximes might be served as a carbonyl ligand or a controlled group playing important roles in the formation
    在温和的反应条件下,通过 N-未保护的靛红肟与芳基硼酸的铜催化偶联,制备了多种 (E)-N-芳基羟吲哚硝酮,收率良好至极好。该反应耐受具有多种敏感官能团的各种芳基硼酸。详细研究表明,靛红肟中的羰基可能作为羰基配体或受控基团在(E)羟吲哚硝酮的形成中起重要作用。这种用于制备 (E)-N-芳基羟吲哚硝酮的方法很容易在克级规模下进行,并且可以有效地以高产率合成雌酮衍生的羟吲哚硝酮。
  • One-pot cascade ring enlargement of isatin-3-oximes to 2,4-dichloroquinazolines mediated by bis(trichloromethyl)carbonate and triarylphosphine oxide
    作者:Jinjing Qin、Zhenhua Li、Shengzhe Ma、Lixian Ye、Guoqiang Jin、Weike Su
    DOI:10.1080/10426507.2020.1782910
    日期:2020.12.1
    Abstract An efficient and convenient one-pot cascade synthesis of 2,4-dichloroquinazolines directly from isatin-3-oximes with the addition of bis(trichloromethyl)carbonate and triarylphosphine oxide was developed, leading to substituted quinazolines in moderate to excellent yields. The efficiency of this transformation was demonstrated by compatibility with a range of functional groups. Thus, the method
    摘要 开发了一种直接从靛红-3-肟与双(三氯甲基)碳酸酯和三芳基膦氧化物直接高效、方便地一锅级联合成 2,4-二氯喹唑啉的方法,以中等至优异的收率获得取代的喹唑啉。与一系列官能团的兼容性证明了这种转化的效率。因此,该方法代表了合成取代的 2,4-二氯喹唑啉的一种方便实用的策略。图形概要
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物